|   Salvianolic acid C structure | Common Name | Salvianolic acid C | ||
|---|---|---|---|---|
| CAS Number | 115841-09-3 | Molecular Weight | 492.431 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 844.2±65.0 °C at 760 mmHg | |
| Molecular Formula | C26H20O10 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 464.4±34.3 °C | |
| Use of Salvianolic acid CSalvianolic acid C is a noncompetitive Cytochrome P4502C8 (CYP2C8) inhibitor and a moderate mixed inhibitor of Cytochrome P45022J2 (CYP2J2), with Kis of 4.82 μM and 5.75 μM for CYP2C8 and CYP2J2, respectively. | 
| Name | (2R)-3-(3,4-Dihydroxyphenyl)-2-({(2E)-3-[2-(3,4-dihydroxyphenyl)- 7-hydroxy-1-benzofuran-4-yl]-2-propenoyl}oxy)propanoic acid | 
|---|---|
| Synonym | More Synonyms | 
| Description | Salvianolic acid C is a noncompetitive Cytochrome P4502C8 (CYP2C8) inhibitor and a moderate mixed inhibitor of Cytochrome P45022J2 (CYP2J2), with Kis of 4.82 μM and 5.75 μM for CYP2C8 and CYP2J2, respectively. | 
|---|---|
| Related Catalog | |
| Target | CYP2C8:4.82 μM (Ki) CYP2J2:5.75 μM (Ki) | 
| In Vitro | Salvianolic acid C is a noncompetitive CYP2C8 inhibitor and a moderate mixed inhibitor of CYP2J2, with Kis of 4.82, 5.75 μM for CYP2C8 and CYP2J2, respectively[1]. 1 and 5 μM Salvianolic acid C (SalC) could significantly inhibit the NO production induced by LPS. Salvianolic acid C decreases the expression of iNOS significantly. Salvianolic acid C inhibits LPS-induced TNF-α, IL-1β, IL-6 and IL-10 overproduction. Salvianolic acid C inhibits LPS-induced NF‑κB activation. Salvianolic acid C also increases the expression of Nrf2 and HO-1 in BV2 microglial cells[2]. | 
| In Vivo | Salvianolic acid C (20 mg/kg) treatment could significantly decrease the escape latency. In addition, SalC (10 and 20 mg/kg) treatment significantly increase the platform crossing number compared with the LPS model group. Systemic administration of Salvianolic acid C down regulates the brain TNF-α, IL-1β and IL-6 levels compared with the model group. The iNOS and COX-2 levels in rat brain cortex and hippocampus are higher than that in the control group, while Salvianolic acid C treatment significantly down regulates the cortex and hippocampus regions. Salvianolic acid C (5, 10 and 20 mg/kg) treatment dose-dependently increases the p-AMPK, Nrf2, HO-1 and NQO1 levels in rat brain cortex and hippocampus[2]. | 
| References | 
| Density | 1.6±0.1 g/cm3 | 
|---|---|
| Boiling Point | 844.2±65.0 °C at 760 mmHg | 
| Molecular Formula | C26H20O10 | 
| Molecular Weight | 492.431 | 
| Flash Point | 464.4±34.3 °C | 
| Exact Mass | 492.105652 | 
| PSA | 177.89000 | 
| LogP | 3.12 | 
| Vapour Pressure | 0.0±3.3 mmHg at 25°C | 
| Index of Refraction | 1.752 | 
| Storage condition | 2-8C | 
| (2R)-3-(3,4-Dihydroxyphenyl)-2-({(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-4-yl]prop-2-enoyl}oxy)propanoic acid | 
| (2R)-3-(3,4-Dihydroxyphenyl)-2-({(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-4-yl]-2-propenoyl}oxy)propanoic acid | 
| Benzenepropanoic acid, α-[[(2E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-4-benzofuranyl]-1-oxo-2-propen-1-yl]oxy]-3,4-dihydroxy-, (αR)- | 
| Salvianolic acid C |